PILL - Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
| Previous Close | 28.81 |
| Open | 29.16 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 800 |
| Day's Range | 27.64 - 29.70 |
| 52 Week Range | 11.23 - 29.70 |
| Volume | 63,182 |
| Avg. Volume | 36,595 |
| Net Assets | 15.2M |
| NAV | 27.77 |
| PE Ratio (TTM) | N/A |
| Yield | 0.38% |
| YTD Daily Total Return | 9.58% |
| Beta (5Y Monthly) | 0.00 |
| Expense Ratio (net) | 0.99% |
| Inception Date | 2017-11-15 |
- Zacks
6 Top-Performing Leveraged ETFs of Last Week
All the three major indices posted their strongest weekly gains since Aug 30 last year.
- Benzinga
Expert: 'I've had far fewer defensive conversations than I would have expected' About The Market
Benzinga: Taken the first few weeks of 2020 into account, what can you even say about this market right now? Jablonski: So, I think if we take a look at where we are today...December was one of the best months for stock gains in 50 years. For investors just trying to come in and evaluate, the valuations might be a little bit high and the risk of getting in them might be higher, too.
- Simply Wall St.
Here's Why We're A Bit Worried About Canntab Therapeutics's (CSE:PILL) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
5 Leveraged ETFs That Gained More Than 20% in October
We have highlighted five leveraged equity ETFs that piled up more than 20% returns in October and could continue to be investors' darlings.
- Simply Wall St.
What Kind Of Shareholder Appears On The Canntab Therapeutics Limited's (CNSX:PILL) Shareholder Register?
If you want to know who really controls Canntab Therapeutics Limited (CNSX:PILL), then you'll have to look at the...
- ETF Trends
4 Hot Pharmaceutical ETFs
Pharmaceutical ETFs invest in stocks of companies that are involved in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. With Johnson and Johnson continuing ...
- ETF Trends
Direxion to Change Indexes For Leveraged Pharma, Real Estate ETFs
Direxion, one of the largest issuers of leveraged exchange traded funds, is planning to change the indexes its leveraged pharmaceuticals and real estate ETFs track. Currently, the Direxion Daily Pharmaceutical ...
- PR Newswire
Direxion Changes Investment Objective and Index of Three Leveraged ETFs
NEW YORK , May 31, 2019 /PRNewswire/ -- The Board of Trustees of the Direxion Shares ETF Trust ("Trust") has approved changes to the investment objective, investment strategy and underlying index ...
- Simply Wall St.
Volatility 101: Should Canntab Therapeutics (CNSX:PILL) Shares Have Dropped 11%?
The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners...
- ETF Trends
4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat
Big pharmaceutical companies were on the hot seat at Capitol Hill today with CVS Health, Cigna, Prime Therapeutics, Humana, and UnitedHealthcare's OptumRx testifying before the Senate Finance Committee on the rising cost of prescription drugs. Among the topics discussed included rebates paid by drug makers contributing to the high costs and the drug industry's pursuit of profits--all to shift the blame from the pharmaceutical companies to the drug makers. U.S. President Donald Trump has already lambasted the pharmaceutical industry for the rising costs associated with prescription drugs.
- ETF Trends
‘PILL’ ETF Gains on $21.4B GE Biopharma Business Sale
The Daily Pharmaceutical & Medical Bull 3X Shares (PILL) gained 1.35 percent on news that General Electric will sell its biopharmaceutical business to conglomerate company Danaher for $21.4 billion. The sale comes as GE CEO Larry Culp is looking to take the company out of its worst slump in its 127-year history.
